Proximagen ^Companies

Proximagen is a leading neuroscience research company that specializes in the development of drugs for neurodegenerative disorders. With a focus on Parkinson's disease and Alzheimer's disease, Proximagen aims to improve the lives of patients suffering from these debilitating conditions. As a publicly traded organization, Proximagen has achieved significant milestones in its drug development efforts, contributing to advancements in the field of neuroscience. Through its innovative research and dedication to finding effective treatments, Proximagen is making a significant impact in the fight against neurodegenerative disorders.